Focus Financial Network Inc. Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Focus Financial Network Inc. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,491 shares of the medical equipment provider’s stock after acquiring an additional 218 shares during the period. Focus Financial Network Inc.’s holdings in Intuitive Surgical were worth $778,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of ISRG. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock valued at $3,587,582 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.3 %

Shares of Intuitive Surgical stock opened at $589.61 on Thursday. The firm’s 50 day simple moving average is $556.91 and its two-hundred day simple moving average is $516.98. The firm has a market capitalization of $210.01 billion, a price-to-earnings ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, UBS Group increased their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.